Coinspeaker Germany to Buy 23% Stake for 300M Euros in CureVac as World Races for COVID-19 VaccineIn a bid to fight off foreign interference, Germany is set to invest in CureVac, a biopharmaceutical firm that is working on the development of a coronavirus vaccine. The deal is worth 300 million EurosGermany to Buy 23% Stake for 300M Euros in CureVac as World Races for COVID-19 Vaccine